Nicola Laurieri

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2

Angela J. Russell, Isaac M. Westwood, Matthew H. J. Crawford et al. · Bioorganic & Medicinal Chemistry · 2008 · 84 citations · Full text

Medicine, Oncology, Pharmacology +10

Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine <i>N</i> -acetyltransferases

Pedro J. Ballester, Isaac M. Westwood, Nicola Laurieri et al. · Journal of The Royal Society Interface · 2009 · 75 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Reaction mechanism of azoreductases suggests convergent evolution with quinone oxidoreductases

Ali Ryan, Chan-Ju Wang, Nicola Laurieri et al. · Protein & Cell · 2010 · 68 citations · Full text

Life Sciences, Biochemistry, Evolutionary Biology +12

PharmGKB summary

Daniel J. Klein, Sotiria Boukouvala, Ellen M. McDonagh et al. · Pharmacogenetics and Genomics · 2016 · 62 citations

Medicine, Pharmacology, Clinical Pharmacology +1

Activation of nitrofurazone by azoreductases: multiple activities in one enzyme

Ali Ryan, Elise Kaplan, Nicola Laurieri et al. · Scientific Reports · 2011 · 58 citations · Full text

Life Sciences, Microbiology, Pharmacology +15